ArticleCureus2026
Central Pontine Myelinolysis and Hypokalemic Paralysis as Initial Manifestations of Primary Sjögren's Syndrome: A Rare Electrolyte-Mediated Neurological Presentation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 63-year-old woman presented with acute quadriparesis and severe hypokalemia (2.07 meq/L) secondary to distal renal tubular acidosis (dRTA), which was later attributed to primary Sjögren's syndrome (SS). Brain MRI revealed a characteristic trident-shaped hyperintense lesion in the central pons on T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences, consistent with central pontine myelinolysis (CPM). The patient had no history of rapid sodium correction, suggesting hypokalemia as the primary trigger for CPM. She was treated with intravenous potassium replacement and intravenous methylprednisolone, followed by oral steroids and hydroxychloroquine. Her neurological symptoms resolved completely within one month, and follow-up MRI showed only residual gliosis. This case highlights two rare neurological manifestations of SS - hypokalemic paralysis and CPM - both resulting from electrolyte disturbances rather than direct autoimmune-mediated nerve damage. While peripheral neuropathy is the most common neurological complication of SS, central nervous system involvement, particularly CPM, is exceedingly rare. This report emphasizes the importance of considering SS in patients with unexplained hypokalemia and acute neurological deficits, as timely diagnosis and treatment can lead to favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.